PARIS--(BUSINESS WIRE)--Theradiag (the theranostics and in vitro diagnostics company focused on autoimmune disease) today announced the appointment of Professor Gérard Tobelem as the new Chairman of the Board of Directors and the arrival of Pierre Morgon and Jean-Paul Prieels as new Board members. This reinforcement of the Board comes after the company's name change (formerly bmd) and heralds its new strategy for developing and marketing theranostics for biologic therapies.
